ASCO: BeiGene, Novartis Herald Global PD-1 Contender In ESCC

Filings Approaching

 
• By Dexter Jie Yan and John Davis
  
Magnifying lens over background with text Immuno-oncology, with the blurred lights visible in the background. 3D rendering.
More Progress For BeiGene's Immuno-Oncology Pipeline • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from ASCO

More from Conferences